ArticleMethodsX2026
Temperature-controlled, chromatography-free synthesis of allobetulin derivatives via trifluoroacetic acid-mediated Wagner-Meerwein rearrangement.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allobetulin derivatives are bioactive lupane-type triterpenoids with promising antiviral, anticancer and anti-inflammatory activities. Conventional synthetic routes rely on harsh acidic conditions and tedious column chromatography purification, leading to low scalability and significant product loss. This study describes a streamlined, one-pot protocol for the synthesis of five allobetulin derivatives from readily available betulin, betulinic acid or betulonic acid, using trifluoroacetic acid (TFA) as a dual-function catalyst and reaction medium. Product selectivity is precisely controlled by reaction temperature, eliminating the need for modifying the reagent system. The method delivers 90-95% isolated yield without chromatographic purification, and the crude product purity exceeds 95% by NMR analysis.•Temperature-dependent selectivity enables access to either C3 free alcohols or C3 trifluoroacetate esters without altering the reaction formulation•Chromatography-free workup minimizes product loss and simplifies isolation for preparative-scale synthesis•Broad substrate scope covering three representative lupane-type triterpenoid scaffolds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.